Home/Versatope Therapeutics/M. P. Anza Mammen, MD
MP

M. P. Anza Mammen, MD

Chief Medical Officer

Versatope Therapeutics

Versatope Therapeutics Pipeline

DrugIndicationPhase
VT-105Universal Influenza APhase 1